Effect of ipratropium bromide in bronchial asthma.

V. Taskar, L. Mirchandani, A. A. Mahashur, R. R. Sharma, V. P. Kolhatkar

Research output: Contribution to journalArticle

Abstract

The effect of inhalation of ipratropium bromide was evaluated in 20 patients with bronchial asthma. It was observed that there was no significant improvement in the forced vital capacity and the forced expired volume in one second, while there was significant improvement in the peak expiratory flow rate (PEFR) measured at 9 pm, after inhalation of 2 puffs of ipratropium bromide aerosol (0.02mg/puff) three to four times a day for 2 weeks. Since PEFR is a measure of large airway function and cholinergic mechanisms are primarily involved for airflow obstruction at large airways, improvement in PEFR by ipratropium bromide highlights its role as a useful bronchodilator in patients in whom vagal reflexes are responsible for the provocation of bronchoconstriction.

Original languageEnglish (US)
Pages (from-to)124-126
Number of pages3
JournalJournal of postgraduate medicine
Volume38
Issue number3
StatePublished - Jan 1 1992

Fingerprint

Ipratropium
Peak Expiratory Flow Rate
Asthma
Inhalation
Bronchoconstriction
Bronchodilator Agents
Vital Capacity
Aerosols
Cholinergic Agents
Reflex

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Taskar, V., Mirchandani, L., Mahashur, A. A., Sharma, R. R., & Kolhatkar, V. P. (1992). Effect of ipratropium bromide in bronchial asthma. Journal of postgraduate medicine, 38(3), 124-126.

Effect of ipratropium bromide in bronchial asthma. / Taskar, V.; Mirchandani, L.; Mahashur, A. A.; Sharma, R. R.; Kolhatkar, V. P.

In: Journal of postgraduate medicine, Vol. 38, No. 3, 01.01.1992, p. 124-126.

Research output: Contribution to journalArticle

Taskar, V, Mirchandani, L, Mahashur, AA, Sharma, RR & Kolhatkar, VP 1992, 'Effect of ipratropium bromide in bronchial asthma.', Journal of postgraduate medicine, vol. 38, no. 3, pp. 124-126.
Taskar V, Mirchandani L, Mahashur AA, Sharma RR, Kolhatkar VP. Effect of ipratropium bromide in bronchial asthma. Journal of postgraduate medicine. 1992 Jan 1;38(3):124-126.
Taskar, V. ; Mirchandani, L. ; Mahashur, A. A. ; Sharma, R. R. ; Kolhatkar, V. P. / Effect of ipratropium bromide in bronchial asthma. In: Journal of postgraduate medicine. 1992 ; Vol. 38, No. 3. pp. 124-126.
@article{92c0069b43ca419daf70b2be83392b48,
title = "Effect of ipratropium bromide in bronchial asthma.",
abstract = "The effect of inhalation of ipratropium bromide was evaluated in 20 patients with bronchial asthma. It was observed that there was no significant improvement in the forced vital capacity and the forced expired volume in one second, while there was significant improvement in the peak expiratory flow rate (PEFR) measured at 9 pm, after inhalation of 2 puffs of ipratropium bromide aerosol (0.02mg/puff) three to four times a day for 2 weeks. Since PEFR is a measure of large airway function and cholinergic mechanisms are primarily involved for airflow obstruction at large airways, improvement in PEFR by ipratropium bromide highlights its role as a useful bronchodilator in patients in whom vagal reflexes are responsible for the provocation of bronchoconstriction.",
author = "V. Taskar and L. Mirchandani and Mahashur, {A. A.} and Sharma, {R. R.} and Kolhatkar, {V. P.}",
year = "1992",
month = "1",
day = "1",
language = "English (US)",
volume = "38",
pages = "124--126",
journal = "Journal of Postgraduate Medicine",
issn = "0022-3859",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

TY - JOUR

T1 - Effect of ipratropium bromide in bronchial asthma.

AU - Taskar, V.

AU - Mirchandani, L.

AU - Mahashur, A. A.

AU - Sharma, R. R.

AU - Kolhatkar, V. P.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The effect of inhalation of ipratropium bromide was evaluated in 20 patients with bronchial asthma. It was observed that there was no significant improvement in the forced vital capacity and the forced expired volume in one second, while there was significant improvement in the peak expiratory flow rate (PEFR) measured at 9 pm, after inhalation of 2 puffs of ipratropium bromide aerosol (0.02mg/puff) three to four times a day for 2 weeks. Since PEFR is a measure of large airway function and cholinergic mechanisms are primarily involved for airflow obstruction at large airways, improvement in PEFR by ipratropium bromide highlights its role as a useful bronchodilator in patients in whom vagal reflexes are responsible for the provocation of bronchoconstriction.

AB - The effect of inhalation of ipratropium bromide was evaluated in 20 patients with bronchial asthma. It was observed that there was no significant improvement in the forced vital capacity and the forced expired volume in one second, while there was significant improvement in the peak expiratory flow rate (PEFR) measured at 9 pm, after inhalation of 2 puffs of ipratropium bromide aerosol (0.02mg/puff) three to four times a day for 2 weeks. Since PEFR is a measure of large airway function and cholinergic mechanisms are primarily involved for airflow obstruction at large airways, improvement in PEFR by ipratropium bromide highlights its role as a useful bronchodilator in patients in whom vagal reflexes are responsible for the provocation of bronchoconstriction.

UR - http://www.scopus.com/inward/record.url?scp=0026894394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026894394&partnerID=8YFLogxK

M3 - Article

C2 - 1303412

AN - SCOPUS:0026894394

VL - 38

SP - 124

EP - 126

JO - Journal of Postgraduate Medicine

JF - Journal of Postgraduate Medicine

SN - 0022-3859

IS - 3

ER -